Sarah has 5+ years of experience strategically supporting clients across the life sciences industry. In particular, Sarah has deep familiarity within oncology, inflammation and fibrosis, and rare disease therapeutic areas. With experience across engagement types, Sarah’s primary strategic focus includes early asset, asset life cycle, and portfolio or therapeutic area planning. She enjoys serving as a critical thought partner to clients, leveraging content expertise and strategic insights to drive to actionable, innovative solutions.
Prior to joining ClearView, Sarah received her Ph.D. in Chemical and Biomolecular Engineering from the University of Pennsylvania, where her thesis work centered on the development and application of human biomimetic angiogenesis models to study disease and development. Sarah received her B.S. in Chemical Engineering from the University of Washington.
Debbi Amanti Belanger
Seth Berman
Klaus Bredl
Steven Chao
Rishi Dalsania
Kim Goh
Ketan Kapadia
Philip Kenner
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Ryan Tubman
Sam Ulin
Debbie Zhuang
Sidnee Pinho
Kristine Hyde
Jim Caruso
Steve Rubman
Lainey Miller
Brian Gibbs
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Dave Konciak
Charles Mathews
Rohit Kumar
Mike Roy
Beko Binder
Jessica Berard
Peter Goldman
Maneesh Gujrati
Austin Hubbert
Jonny Juliano
Owen Im
Andrew Kang
Patrick Kuettner
Joanna Lee
Alexander Lehrman
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Olivia Piccione
Matthew Pfister
Kai-Ming Pu
Sarah Stapleton
Kelsey Yardumian